Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment

Clinical trial NCT04723472 · SUSPENDED

Trial details

NCT number: NCT04723472
Sponsor: Shanghai East Hospital
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2023-08-01
Primary completion: 2025-12-31
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.